Bookbuilding IPO | ₹13 Cr | Listed at BSE SME | Tue, Sep 23, 2025 - Thu, Sep 25, 2025
Aptus Pharma IPO is a book build issue of ₹13.02 crores. The issue is entirely a fresh issue of 0.19 crore shares of ₹13.02 crore.
Aptus Pharma IPO bidding started from Sep 23, 2025 and ended on Sep 25, 2025. The allotment for Aptus Pharma IPO was finalized on Sep 26, 2025. The shares got listed on BSE SME on Sep 30, 2025.
Aptus Pharma IPO price band is set at ₹70 per share. The lot size for an application is 2,000. The minimum amount of investment required by an individual investor (retail) is ₹2,80,000 (4,000 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (6,000 shares), amounting to ₹4,20,000.
Interactive Financial Services Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Market-Hub Stock Broking Pvt.Ltd..
Refer to Aptus Pharma IPO RHP for detailed Information.
IPO Open
Tue, Sep 23, 2025
IPO Close
Thu, Sep 25, 2025
Issue Price
₹70 per share
Market Cap (Pre-IPO)
₹48.02 Cr
| IPO Date | 23 to 25 Sep, 2025 |
| Listed on | Tue, Sep 30, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹65 to ₹70 |
| Issue Price | ₹70 per share |
| Lot Size | 2,000 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Total Issue Size | 18,60,000 shares (agg. up to ₹13 Cr) |
| Reserved for Market Maker | 94,000 shares Market-Hub Stock Broking Pvt.Ltd. (agg. up to ₹0.6580 Cr) |
| Fresh Issue (Ex Market Maker) | 17,66,000 shares (agg. up to ₹12 Cr) |
| Net Offered to Public | 17,66,000 shares (agg. up to ₹12 Cr) |
| Share Holding Pre Issue | 50,00,000 shares |
| Share Holding Post Issue | 68,60,000 shares |
| BSE Script Code | 544529 |
| ISIN | INE15XJ01010 |
Aptus Pharma IPO comprises a total issue size of 18,60,000 shares. The net offer to the public is 17,66,000 shares, after excluding 94,000 shares allotted on a firm basis. Of the Net offer 8,80,000 (49.83%) are allocated to QIB, 2,66,000 (15.06%) allocated to NII 6,20,000 (35.11%) allocated to RII.
| Investor Category | Shares Offered | % of Net Issue | % of Total Issue |
|---|---|---|---|
| QIB Shares Offered | 8,80,000 | 49.83% | 47.31% |
| − Anchor Investor Shares Offered | 5,28,000 | 28.39% | |
| − QIB (Ex. Anchor) Shares Offered | 3,52,000 | 18.92% | |
| NII (HNI) Shares Offered | 2,66,000 | 15.06% | 14.30% |
| − bNII > ₹10L | 1,78,000 | 9.57% | |
| − sNII < ₹10L | 88,000 | 4.73% | |
| Retail Shares Offered | 6,20,000 | 35.11% | 33.33% |
| Firm Reservations | |||
| Market Maker Shares Offered | 94,000 | 5.05% | |
| Total Shares Offered | 18,60,000 | 100.00% | 100.00% |
Investors can bid for a minimum of 4,000 shares and in multiples of 2,000 shares thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 4,000 | ₹2,80,000 |
| Individual investors (Retail) (Max) | 2 | 4,000 | ₹2,80,000 |
| S-HNI (Min) | 3 | 6,000 | ₹4,20,000 |
| S-HNI (Max) | 7 | 14,000 | ₹9,80,000 |
| B-HNI (Min) | 8 | 16,000 | ₹11,20,000 |
Aptus Pharma IPO raises ₹3.70 crore from anchor investors. Aptus Pharma IPO Anchor bid date is September 22, 2025.
📝 Anchor Investors Letter (PDF)
| Bid Date | Mon, Sep 22, 2025 |
| Shares Offered | 5,28,000 |
| Anchor Portion (₹ Cr.) | 3.70 |
| Anchor lock-in period end date for 50% shares (30 Days) | Sun, Oct 26, 2025 |
| Anchor lock-in period end date for remaining shares (90 Days) | Thu, Dec 25, 2025 |
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulations
The company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.
Products:
As of March 31, 2025, the company has 194 pharmaceutical formulations in more than eleven therapeutic segments.
Its warehouse is located over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution model includes 125 direct and sub distributors and a sales team of 54 field personnel.
As of March 31, 2025, the company had 70 employees.
Competitive Strengths
Aptus Pharma Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 21.92 | 10.03 | 6.22 |
| Total Income | 24.64 | 17.88 | 13.90 |
| Profit After Tax | 3.10 | 0.80 | 0.19 |
| EBITDA | 4.76 | 1.49 | 0.57 |
| NET Worth | 6.97 | 1.77 | 0.97 |
| Reserves and Surplus | 1.97 | 1.47 | 0.67 |
| Total Borrowing | 10.36 | 5.31 | 2.21 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Capital Expenditure for Office Premises with furniture and Industrial Racks | 1.63 |
| 2 | Working Capital | 8.00 |
| 3 | General corporate purposes | 1.91 |
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 44.50% |
| ROCE | 45.66% |
| Debt/Equity | 1.49 |
| RoNW | 44.50% |
| PAT Margin | 12.62% |
| EBITDA Margin | 19.31% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 6.20 | 4.52 |
| P/E (x) | 11.29 | 15.49 |
| Promoter Holding | 100% | 72.89% |
| Market Cap | ₹48.02 Cr. |
The Aptus Pharma IPO is subscribed 22.27 times on September 25, 2025 5:04:42 PM (Day 3). The public issue subscribed 31.43 times in the individual investors category, 1.24 times in the QIB category, and 28.75 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for | Total Application |
|---|---|---|---|---|
| QIB (Ex Anchor) | 1.24 | 3,52,000 | 4,36,000 | 0 |
| NII* | 28.75 | 2,66,000 | 76,48,000 | 0 |
| bNII (bids above ₹10L) | 30.64 | 1,78,000 | 54,54,000 | |
| sNII (bids below ₹10L) | 24.93 | 88,000 | 21,94,000 | |
| Individual Investors | 31.43 | 6,20,000 | 1,94,88,000 | 0 |
| Total | 22.27 | 12,38,000 | 2,75,72,000 | 5,590 |
Total Application : 5,590
*Market Maker portion is not included to NII/HNI.
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Lead Manager Fees including Underwriting Commission | 0.93 |
| 2 | Brokerage, selling commission and Marketing | 0.21 |
| 3 | Registrar to the Issue | 0.01 |
| 4 | Legal Advisors | 0.02 |
| 5 | Advertising and marketing expenses | 0.07 |
| 6 | Regulators including stock exchanges | 0.08 |
| 7 | Printing and distribution of issue stationary | 0.04 |
| 8 | Others (Market Making fees etc.) | 0.12 |
| Price Details | BSE SME |
|---|---|
| Final Issue Price | ₹70.00 |
| Open | ₹80.80 |
| Low | ₹80.80 |
| High | ₹84.84 |
| Last Trade | ₹84.84 |
Lead Manager Reports
Aptus Pharma IPO is a SME IPO of 18,60,000 equity shares of the face value of ₹10 aggregating up to ₹13 Crores. The issue is priced at ₹70 per share. The minimum order quantity is 2000.
The IPO opens on Tue, Sep 23, 2025, and closes on Thu, Sep 25, 2025.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
Zerodha customers can apply online in Aptus Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Aptus Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Aptus Pharma IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Aptus Pharma IPO opens on Tue, Sep 23, 2025 and closes on Thu, Sep 25, 2025.
Aptus Pharma IPO lot size is 2000, and the minimum amount required for application is ₹2,80,000, with 2 lots being the minimum application size.
You can apply in Aptus Pharma IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Aptus Pharma IPO will be done on Friday, September 26, 2025, and the allotted shares will be credited to your demat account by Mon, Sep 29, 2025. Check the Aptus Pharma IPO allotment status.
The Aptus Pharma IPO listing date is on Tue, Sep 30, 2025.
